RayzeBio, Inc.

YTD

ALL

Why Robinhood?

You can watch RayzeBio, Inc. and buy or sell other stocks, ETFs, and their options commission-free!

About RYZB

Rayzebio, Inc. provides radiopharmaceutical medicines for cancer. It develops a pipeline against validated oncology drug targets to deliver radioisotopes that emit alpha particles such as Actinium-225.

CEO

Kenneth Song, MD

CEOKenneth Song, MD

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2020

Founded2020

Employees

—

Employees—

RYZB Key Statistics

Market cap

3.74B

Market cap3.74B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

44.41K

Average volume44.41K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$62.51

52 Week high$62.51

52 Week low

$17.95

52 Week low$17.95

People also own

Based on the portfolios of people who own RYZB. This list is generated using Robinhood data, and it’s not a recommendation.